Sangamo Therapeutics Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. META
5. QQQ
6. LDOS
7. PLTR
8. CSCO
9. KTOS
10. NVDA

Go back to Sangamo Therapeutics Reports Third Quarter 2018 Financial Results

Sangamo Therapeutics (SGMO) Misses Q3 EPS by 13c

November 8, 2018 4:02 PM EST

Sangamo Therapeutics (NASDAQ: SGMO) reported Q3 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $23.6 million versus the consensus estimate of $26.96 million.

For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.

... More